RE: Read this30 Mar 2020 15:59
Tissue Regenix Group PLC - medical devices firm - Has enough cash to support working capital requirements until end of second week of May 2020, but is still looking to secure necessary funding. San Antonio facility remains operational with no hit to processing. Demand for BioRinse portfolio continues to exceed capacity, and company experiences no material reduction in net revenue.
Above reading is generally ok, the finance is the stumbling block. let’s see what they can do about that in coming weeks ahead. It sounds like they are exploring different options in today’s RNS and are encouraged. Talks must be advanced by now. Let’s see what happens. Truth is know-body here knows